CONFIRMEDDate confidence: CONFIRMEDStated as firmHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all CONFIRMED pins84% CONFIDENCEOverall confidence: 84%How well the pin's source and references back up its dates.Weighted average of how firmly 3 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better
Pfizer's release (Business Wire copy on Nasdaq[1]) is stamped Nov 13, 2025 and says 'as of November 13, 2025'; BioSpace[3] carried it the next day.On 13 November 2025 Pfizer completed its acquisition of obesity biotech Metsera for US$65.60 per share in cash, an enterprise value of about US$7.0 billion, plus a contingent value right of up to US$20.65 per share.
$7B
1.00